Abstract

The role of natural killer (NK; CD3-CD56+)/NKT (CD3+CD56+)-like cells in chikungunya virus (CHIKV) disease progression/recovery remains unclear. Here, we investigated the expression profiles and function of NK and NKT-like cells from 35 chronic chikungunya patients, 30 recovered individuals, and 69 controls. Percentage of NKT-like cells was low in chronic chikungunya patients. NKp30+, CD244+, DNAM-1+, and NKG2D+ NK cell percentages were also lower (MFI and/or percentage), while those of CD94+ and NKG2A+ NKT-like cells were higher (MFI and/or percentage) in chronic patients than in recovered subjects. IFN-γ and TNF-α expression on NKT-like cells was high in the chronic patients, while only IFN-γ expression on NK cells was high in the recovered individuals. Furthermore, percentage of perforin+NK cells was low in the chronic patients. Lower cytotoxic activity was observed in the chronic patients than in the controls. CD107a expression on NK and NKT-like cells post anti-CD94/anti-NKG2A blocking was comparable among the patients and controls. Upregulated inhibitory and downregulated activating NK receptor expressions on NK/NKT-like cells, lower perforin+ and CD107a+NK cells are likely responsible for inhibiting the NK and NKT-like cell function in the chronic stage of chikungunya. Therefore, deregulation of NKR expression might underlie CHIKV-induced chronicity.

Highlights

  • The chikungunya virus (CHIKV)is a positive-sense, single-stranded RNA virus of the Alphavirus genus belonging to the family Togaviridae [1]

  • Impaired functionality of natural killer (NK) cells in chronic chikungunya that limit viral dissemination/establishment of chronicity in chikungunya disease. Immune effector cells, such as NK cells, have been implicated in the early control of various viral infections; it was of interest to investigate the intrinsic association between deregulated NK cell surface receptors (NKRs) expression and lymphocyte function in both chronic patients and individuals recovered from chikungunya infection

  • Impairment of NK cell function in the chronic patients, irrespective of NK cell percentage being comparable with the controls, may be a specific phenomenon indicating that the functional capacity per NK cell in the chronic chikungunya patients is low

Read more

Summary

Introduction

The chikungunya virus (CHIKV)is a positive-sense, single-stranded RNA virus of the Alphavirus genus belonging to the family Togaviridae [1]. CHIKV belongs to the arthritogenic group of alphaviruses transmitted through the Aedes group of mosquitoes [2,3,4]. Re-emergence of chikungunya, with higher medical complications,since 2006 in several Asian and African countries, is a significant public health concern. Chikungunya outbreaks have been reported in America and the Caribbean Islands in late 2013 [5, 6]. Chikungunya is a self-limiting disease usually resolved in acute stage, persistent joints pain lasts for several months or even years in 10–20% of patients after the initial infection [3, 7,8,9,10,11].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.